See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Liberation Day
Tariffs
Donald Trump
Trade War
Natural Disasters
Baseball
Senate
Republican Party
Social Media
Artificial Intelligence
Democratic Party
Tennis
Published • loading... • Updated

NeuroNOS Raises $2M in Funding

Summary by FinSMEs
NeuroNOS, a Boston, MA-based biopharmaceutical company focused on developing treatments for Autism Spectrum Disorder (ASD) and other complex neurological conditions, raised $2M in funding. Backers were not disclosed. The company intends to use the funds to accelerate the preclinical development of its small-molecule drug, designed as an injectable or oral treatment for children with autism. […] The post NeuroNOS Raises $2M in Funding appeared fi…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Pharmaceutical Business reviewPharmaceutical Business review

NeuroNOS secures funding for autism treatment development

The treatment, designed to be administered either as an injectable or an oral medication, utilises the regulation of the brain’s nitric oxide (NO) levels to influence neurological function. The post NeuroNOS secures funding for autism treatment development appeared first on Pharmaceutical Business review.

Read Full Article
FinSMEsFinSMEs

NeuroNOS Raises $2M in Funding

NeuroNOS, a Boston, MA-based biopharmaceutical company focused on developing treatments for Autism Spectrum Disorder (ASD) and other complex neurological conditions, raised $2M in funding. Backers were not disclosed. The company intends to use the funds to accelerate the preclinical development of its small-molecule drug, designed as an injectable or oral treatment for children with autism. […] The post NeuroNOS Raises $2M in Funding appeared fi…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

FinSMEs broke the news in on Tuesday, March 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Boston, Massachusetts

Boston, Massachusetts

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal